Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,656 | 142 | 61.8% |
| Travel and Lodging | $2,167 | 7 | 36.6% |
| Education | $90.95 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,620 | 17 | $0 (2024) |
| ABBVIE INC. | $894.21 | 31 | $0 (2022) |
| Gilead Sciences, Inc. | $385.41 | 12 | $0 (2023) |
| Janssen Biotech, Inc. | $385.24 | 11 | $0 (2023) |
| PFIZER INC. | $310.87 | 11 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $235.78 | 16 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $179.14 | 5 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $163.85 | 10 | $0 (2022) |
| Aries Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
| ERBE USA Inc | $108.28 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $136.30 | 2 | Boston Scientific Corporation ($113.70) |
| 2023 | $1,418 | 9 | Boston Scientific Corporation ($1,236) |
| 2022 | $320.62 | 11 | ABBVIE INC. ($187.74) |
| 2021 | $1,164 | 28 | BOSTON SCIENTIFIC CORPORATION ($560.07) |
| 2020 | $372.40 | 14 | Intercept Pharmaceuticals, Inc. ($139.71) |
| 2019 | $1,079 | 26 | Boston Scientific Corporation ($541.93) |
| 2018 | $945.42 | 34 | Gilead Sciences, Inc. ($133.00) |
| 2017 | $477.74 | 26 | BOSTON SCIENTIFIC CORPORATION ($111.10) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/19/2024 | Boston Scientific Corporation | Spyglass (Device) | Travel and Lodging | Cash or cash equivalent | $113.70 | General |
| Category: Spyglass DS_ENDO | ||||||
| 04/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/04/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $57.51 | General |
| Category: EXALT_ENDO | ||||||
| 11/03/2023 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $231.23 | General |
| Category: General - Therapies_ENDO | ||||||
| 11/03/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $50.34 | General |
| Category: General - Therapies_ENDO | ||||||
| 11/03/2023 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $44.02 | General |
| Category: EXALT_ENDO | ||||||
| 11/02/2023 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $621.60 | General |
| Category: General - Therapies_ENDO | ||||||
| 11/02/2023 | Boston Scientific Corporation | — | Travel and Lodging | In-kind items and services | $231.23 | General |
| Category: General - Therapies_ENDO | ||||||
| 02/28/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.28 | General |
| 01/26/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 01/11/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.14 | General |
| 12/02/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.30 | General |
| 11/17/2022 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: VIROLOGY | ||||||
| 11/03/2022 | Organon LLC | RENFLEXIS (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: INFLIXIMAB | ||||||
| 10/26/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/13/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $124.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/16/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $15.40 | General |
| 07/27/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Gastroenterology | ||||||
| 06/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2022 | Nestle HealthCare Nutrition Inc. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/04/2022 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.23 | General |
| 04/26/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $88.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2021 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: HCV | ||||||
| 10/27/2021 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 102 | 119 | $27,171 | $7,895 |
| 2022 | 11 | 318 | 349 | $98,277 | $30,577 |
| 2021 | 14 | 482 | 529 | $130,048 | $51,377 |
| 2020 | 10 | 450 | 503 | $137,669 | $45,387 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 28 | $6,278 | $2,955 | 47.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 28 | 28 | $14,546 | $2,032 | 14.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 49 | $4,275 | $1,967 | 46.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 14 | 14 | $2,072 | $940.80 | 45.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 52 | 54 | $11,016 | $5,342 | 48.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 21 | 22 | $11,932 | $4,243 | 35.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 28 | 29 | $15,892 | $4,020 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 48 | $6,768 | $3,240 | 47.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $19,717 | $3,071 | 15.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 51 | $5,508 | $2,792 | 50.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $6,092 | $2,316 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 27 | $5,336 | $2,230 | 41.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,069 | $1,226 | 39.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 18 | $11,214 | $1,200 | 10.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 28 | 29 | $1,733 | $895.58 | 51.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 41 | 42 | $19,644 | $8,018 | 40.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 71 | 73 | $13,943 | $7,801 | 56.0% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 51 | 53 | $24,438 | $7,298 | 29.9% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 72 | 73 | $15,931 | $5,606 | 35.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 37 | 63 | $6,363 | $3,637 | 57.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 34 | $6,392 | $3,383 | 52.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 47 | $6,215 | $3,270 | 52.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 16 | 16 | $8,889 | $2,628 | 29.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2021 | 13 | 13 | $6,682 | $2,465 | 36.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 25 | 25 | $11,650 | $2,154 | 18.5% |
About Dr. Charles Ruzkowski, MD
Dr. Charles Ruzkowski, MD is a Gastroenterology healthcare provider based in Pueblo, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669576757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Ruzkowski, MD has received a total of $5,914 in payments from pharmaceutical and medical device companies, with $136.30 received in 2024. These payments were reported across 150 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($3,656).
As a Medicare-enrolled provider, Ruzkowski has provided services to 1,352 Medicare beneficiaries, totaling 1,500 services with total Medicare billing of $135,236. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Pueblo, CO
- Active Since 09/11/2006
- Last Updated 05/01/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1669576757
Products in Payments
- RESOLUTION CLIP (Device) $543.10
- GENERAL POLYPECTOMY (Device) $446.31
- XELJANZ (Drug) $298.62
- STELARA (Biological) $294.29
- Epclusa (Drug) $246.96
- HUMIRA (Biological) $242.54
- CREON (Drug) $204.70
- ELEVIEW (Device) $125.00
- Humira (Biological) $114.19
- Spyglass (Device) $113.70
- LINZESS (Drug) $112.23
- MAVYRET (Drug) $109.17
- XIFAXAN (Drug) $104.12
- EXALT Model D (Device) $101.53
- ENTYVIO (Biological) $99.48
- REMICADE (Biological) $90.95
- GENERAL BILIARY DEVICES (Device) $90.58
- VIO300D (Device) $82.50
- OTHER- BSC PRODUCT NOT LISTED (Device) $76.70
- Trulance (Drug) $70.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Pueblo
Dr. Sung Yang, M.d, M.D
Gastroenterology — Payments: $5,539
Paula Dionisio, M.d, M.D
Gastroenterology — Payments: $2,698
Lirio Polintan, Md, MD
Gastroenterology — Payments: $2,146
Mena Tawfik, Md, MD
Gastroenterology — Payments: $1,345
Dr. Henrique Fernandez, Md, MD
Gastroenterology — Payments: $1,211
Maritza Proano, M.d, M.D
Gastroenterology — Payments: $110.51